Development Of A High Performance Covid-19 Immunoassay, An Essential Tool To Establish Immunity Passports In The Luxembourgish Population (COV-Immun)
- Funded by Luxembourg National Research Fund
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$54,000Funder
Luxembourg National Research FundPrincipal Investigator
Christiane HilgerResearch Location
LuxembourgLead Research Institution
Luxembourg Institute of Health (LIH)Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The current situation of lock-down in many countries creates a strong need for large screening efforts in order to assess the immune status of the population and to advice decision makers on measures to relaunch social and economic activites. Due to the critical need for serological testing on high numbers of individuals over several months, shortages are predictable and a major threat to society. The present proposal aims at the setup of a high-performance and flexible diagnostic assay using an immunodetection technique and recombinant viral surface proteins expressed and purified in Luxembourg, which can be readily adapted to changing needs, such as the inclusion of newly emerging specific virus strains in routine testing or the targeted monitoring of immune response kinetics in clinical studies.